SCHEMBL29593202

SCHEMBL29593202

COC(=O)Nc1cnc(Cn2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)cn1

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 20/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28899058 1.00 MAPK14 (0.59) MAPK14
SCHEMBL6472008 0.91 MAPK14 (0.66) MAPK14
SCHEMBL6503302 0.90 MAPK14 (0.57) MAPK14
SCHEMBL4387510 0.87 MAPK14 (0.67) MAPK14
SCHEMBL4376308 0.86 MAPK14 (0.75) MAPK14
SCHEMBL6501122 0.85 MAPK14 (0.65) MAPK14
SCHEMBL4375892 0.85 MAPK14 (0.69) MAPK14
SCHEMBL6502768 0.85 MAPK14 (0.64) MAPK14
SCHEMBL4379463 0.84 MAPK14 (0.68) MAPK14
SCHEMBL4376131 0.84 MAPK14 (0.63) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114748622-A P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD 弗尔康医疗公司 2022-07-15 CN disclosed
CN-114732910-A P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-07-12 CN disclosed
CN-111601593-B P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-04-15 CN disclosed